Artemis Medicare Services Ltd.

NSE: ARTEMISMED BSE: 542919 SECTOR: Hospital & Healthcare Services  8294   25   3

54.05
-1.55 (-2.79%)
NSE: Today, 03:54 PM

Price Summary

Today's High

₹ 56.55

Today's Low

₹ 53.75

52 Week High

₹ 58.75

52 Week Low

₹ 31.32

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

719.55 Cr.

Enterprise Value

808.42 Cr.

No. of Shares

13.31 Cr.

P/E

19.39

P/B

2.43

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  22.21

CASH

28.85 Cr.

DEBT

117.71 Cr.

Promoter Holding

69.59 %

EPS (TTM)

₹  2.79

Sales Growth

-28.6%

ROE

2.82 %

ROCE

5.93%

Profit Growth

-65.31 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year35.5%
3 Year-0.11%
5 Year3.49%

Profit Growth

1 Year359.67%
3 Year16.34%
5 Year3.78%

ROE%

1 Year12.02%
3 Year7.89%
5 Year10.42%

ROCE %

1 Year11.89%
3 Year10.28%
5 Year13.05%

Debt/Equity

0.6021

Price to Cash Flow

26.36

Interest Cover Ratio

1.72589229678292

CFO/PAT (5 Yr. Avg.)

2.49088776208219

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2022 69.59 0
Mar 2022 69.82 0
Dec 2021 69.82 0
Sep 2021 69.82 0
Jun 2021 69.82 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of -138.584452351669 days.
  • The company has a good cash flow management; CFO/PAT stands at 2.49088776208219.
  • The company has a high promoter holding of 69.82%.

 Limitations

  • The company has shown a poor profit growth of -35.7895596449441% for the Past 3 years.
  • The company has shown a poor revenue growth of -7.1800217951964% for the Past 3 years.
  • Company has a poor ROE of 7.88713763501803% over the past 3 years.
  • The company is trading at a high PE of 19.39.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022
Net Sales 120.48 136.32 141.79 146.2 163.47
Total Expenditure 107.51 116.74 124.02 129.35 144.19
Operating Profit 12.98 19.58 17.77 16.85 19.28
Other Income 0.8 0.85 0.99 1.24 2.27
Interest 2.19 2.48 3 3.5 4.1
Depreciation 4.81 4.88 5.31 6.09 6.27
Exceptional Items 0 0 0 0 0
Profit Before Tax 6.79 13.07 10.45 8.5 11.17
Tax 2.63 4.71 3.72 -4.82 2.47
Profit After Tax 4.16 8.37 6.73 13.32 8.7
Adjusted EPS (Rs) 0.31 0.63 0.51 1.01 0.66

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 502.77 546.52 563.09 402.06 544.78
Total Expenditure 443.28 482.4 500.85 367.02 477.61
Operating Profit 59.49 64.11 62.24 35.05 67.17
Other Income 3.91 4 4.57 3.55 3.88
Interest 9.46 11 12.51 12.27 11.17
Depreciation 18.47 20.07 22.33 20.65 21.08
Exceptional Items 0 0 0 3.23 0
Profit Before Tax 35.47 37.04 31.97 8.91 38.81
Tax 8.7 16.36 11.54 1.82 6.23
Net Profit 26.77 20.69 20.43 7.09 32.58
Adjusted EPS (Rs.) 1.27 0 1.54 0.54 2.46

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 21.04 0 13.24 13.24 13.24
Total Reserves 210.02 293.66 300.83 308.38 348.37
Borrowings 52.25 53.46 60.57 98.77 152.57
Other N/C liabilities 21.07 30.8 49.67 61.42 66.92
Current liabilities 147.48 176.63 156.85 115.68 133.08
Total Liabilities 451.85 554.54 581.16 597.5 714.19
Assets
Net Block 308.52 380.68 387.13 371.82 476.05
Capital WIP 43.17 49.43 55.69 81.01 62.11
Intangible WIP 0 0 0 0 1.94
Investments 0 0.07 1.69 4.29 5.59
Loans & Advances 11.49 10.99 19.31 34.43 45.3
Other N/C Assets 1.35 0.69 0.59 0.25 0.57
Current Assets 87.32 112.68 116.75 105.7 122.63
Total Assets 451.85 554.54 581.16 597.5 714.19
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations 35.47 37.04 31.97 8.91 38.81
Adjustment 13.62 26.21 33.84 28.68 36.34
Changes in Assets & Liabilities 23.71 -12.86 -5.15 -8.17 1.9
Tax Paid -0.9 -9.85 -4.17 -2.37 -16.33
Operating Cash Flow 71.91 40.54 56.49 27.04 60.71
Investing Cash Flow -66.57 -49.61 -21.52 -34.08 -106.1
Financing Cash Flow -9.67 14.37 -33.01 12.73 43.61
Net Cash Flow -4.33 5.3 1.96 5.69 -1.77

Corporate Actions

Investors Details

PARTICULARS Jun 2021% Sep 2021% Dec 2021% Mar 2022% Jun 2022%
Promoters 69.82 69.82 69.82 69.82 69.59
constructive finan... - - - 69.82 -
constructive finan... 69.82 69.82 69.82 - 69.58
PARTICULARS Jun 2021% Sep 2021% Dec 2021% Mar 2022% Jun 2022%
Investors 30.18 30.18 30.18 30.18 30.41
governor of kerala 5.10 5.10 5.10 5.10 5.08
kerala state indus... - - - 2.27 -
kerala state indus... 2.27 2.27 2.27 - 2.26
rafique dawood 1.06 - - - -
artemis medicare s... 1.42 1.42 1.42 - -
artemis medicare s... - - - 1.42 1.41
ashok kumar jain 1.34 1.34 1.17 1.15 1.21

Annual Reports

Ratings & Research Reports

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Artemis Medicare Stock Price Analysis and Quick Research Report. Is Artemis Medicare an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Artemis Medicare and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 27.2939 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Artemis Medicare has a Debt to Equity ratio of 0.4612 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Artemis Medicare , the EPS growth was -65.3074411478194 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Artemis Medicare has OPM of 8.71715103850461 % which is a bad sign for profitability.
     
  • ROE: Artemis Medicare have a poor ROE of 2.81615705089297 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Artemis Medicare

X